| [1] |
Beers MF, Moodley Y. When is an alveolar type 2 cell an alveolar type 2 cell? a conundrum for lung stem cell biology and regenerative medicine[J]. Am J Respir Cell Mol Biol, 2017, 57(1):18-27.
|
| [2] |
Guillot L, Nathan N, Tabary O, et al. Alveolar epithelial cells: master regulators of lung homeostasis[J]. Int J Biochem Cell Biol, 2013, 45(11):2568-2573.
|
| [3] |
Selman M, Thannickal VJ, Pardo A, et al. Idiopathic pulmonary fibrosis[J]. Semin Resp Crtt Care, 2011, 378(9807):1949.
|
| [4] |
Geiser T. Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?[J]. Swiss Med Wkly, 2003, 133(29/30):405-411.
|
| [5] |
Crapo JD, Young SL, Fram EK, et al. Morphometric characteristlcs of cells in the alveolar region of mammalian lungs[J]. Am Rev Respir Dis, 1983, 128(2 Pt 2):S42-46.
|
| [6] |
Baritussio AG, Magoon MW, Goerke J. Precursor-product relationship between rabbit typeⅡcell lamellar bodies and alveolar surface-active material.Surfactant turnover time[J]. Biochim Biophys Acta, 1981, 666(3):382-393.
|
| [7] |
Mason RJ. Biology of alveolar typeⅡcells[J]. Respirology, 2006, 11(S):S12-S15.
|
| [8] |
Lopez-Rodriguez E, Pérez-Gil J. Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy[J]. Biochim Biophys Acta, 2014, 1838(6):1568-1585.
|
| [9] |
Guth AM, Janssen WJ, Bosio CM, et al. Lung environment determines unique phenotype of alveolar macrophages[J]. Am J Physiol Lung Cell Mol Physiol, 2009, 296(6):L936-L946.
|
| [10] |
Hussell T, Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context[J]. Nat Rev Immunol, 2014, 14(2):81-93.
|
| [11] |
O'Brien AD, Standiford TJ, Christensen PJ, et al. Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells[J]. J Lab Clin Med,1998,131(5):417-424.
|
| [12] |
Fehrenbach H. Alveolar epithelial typeⅡcell: defender of the alveolus revisited[J]. Respir Res, 2001, 2(1):33-52.
|
| [13] |
Minoo P, King RJ. Epithelial-mesenchymal interactions in lung development[J]. Annu Rev Physiol, 1994, 56:13-45.
|
| [14] |
Haschek WM, Witschi H. Pulmonary fibrosis--a possible mechanism[J]. Toxicol Appl Pharmacol, 1979, 51(3):475-487.
|
| [15] |
Barbas-Filho JV, Ferreira MA, Sesso A, et al. Evidence of typeⅡ pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis(IFP)/usual interstitial pneumonia(UIP)[J]. J Clin Pathol, 2001, 54(2):132-138.
|
| [16] |
Sisson TH, Mendez M, Choi K, et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2010, 181(3):254-263.
|
| [17] |
Tanjore H, Blackwell TS, Lawson WE. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis[J]. Am J Physiol Lung Cell Mol Physiol, 2012, 302(8):L721-L729.
|
| [18] |
Maitra M, Wang YY, Gerard RD, et al. Surfactant protein a2 mutations associated with pulmonary fibrosis Lead to protein instability and endoplasmic reticulum stress[J]. J Biol Chem, 2010, 285(29):22103-22113.
|
| [19] |
Nogee LM, Dunbar AE, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease[J]. N Engl J Med, 2001, 344(8):573-579.
|
| [20] |
Lawson WE, Crossno PF, Polosukhin VV, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(6):L1119-L1126.
|
| [21] |
Korfei M, Ruppert C, Mahavadi P, et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2008, 178(8):838-846.
|
| [22] |
Mulugeta S, Nguyen V, Russo SJ, et al. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation[J]. Am J Respir Cell Mol Biol, 2005, 32(6):521-530.
|
| [23] |
Mulugeta S, Maguire JA, Newitt JL, et al. Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms[J]. Am J Physiol Lung Cell Mol Physiol, 2007, 293(3):L720-L729.
|
| [24] |
Lawson WE, Cheng DS, Degryse AL, et al. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs[J]. Proc Natl Acad Sci U S A, 2011, 108(26):10562-10567.
|
| [25] |
O'Dwyer DN, Ashley SL, Moore BB. Influences of innate immunity, autophagy and fibroblast activation in the pathogenesis of lung fibrosis[J]. Am J Physiol Lung Cell Mol Physiol, 2016, 11(3):L590-601.
|
| [26] |
Wang K, Zhang T, Lei YL, et al. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux[J]. Autophagy, 2018, 14(2):269-282.
|
| [27] |
Tomohiro Y, Usha N, Zhifen Y, et al. Endoplasmic reticulum stress triggers autophagy[J]. J Biol Chem, 2006, 281(40):30299-30304.
|
| [28] |
Bueno M, Lai YC, Romero Y, et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis[J]. J Clin Invest, 2015, 125(2):521-538.
|
| [29] |
Birkelbach B, Lutz D, Ruppert C, et al. Linking progression of fibrotic lung remodeling and ultrastructural alterations of alveolar epithelial typeⅡcells in the amiodarone mouse model[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(1):L63-L75.
|
| [30] |
Mahavadi P, Knudsen L, Venkatesan S, et al. Regulation of macroautophagy in amiodarone-induced pulmonary fibrosis[J]. J Pathol Clin Res, 2015, 1(4):252-263.
|
| [31] |
Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis[J]. N Engl J Med, 2007, 356(13):1317-1326.
|
| [32] |
Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase[J]. Proc Natl Acad Sci U S A, 2007, 104(18):7552-7557.
|
| [33] |
Camelo A, Dunmore R, Sleeman MA, et al. The epithelium in idiopathic pulmonary fibrosis: breaking the barrier[J]. Front Pharmacol, 2014, 4:173.
|
| [34] |
Caja L, Dituri F, Mancarella S, et al. TGF-β and the tissue microenvironment: relevance in fibrosis and cancer[J]. Int J Mol Sci, 2018, 19(5): pii: E1294.
|
| [35] |
Knudsen L, Lopez-Rodriguez E, Berndt L, et al. Pressure dependent alveolar derecruitment is linked with surfactant dysfunction in Bleomycin-Induced acute lung injury[J]. Am J Respir Crit Care Med, 2016, 193:A4813.
|
| [36] |
Knudsen L, Ruppert C, Ochs M. Tissue remodelling in pulmonary fibrosis[J]. Cell Tissue Res, 2017, 367(3):607-626.
|
| [37] |
Funke M, Zhao ZW, Xu Y, et al. The lysophosphatidic acid receptor LPA(1) promotes epithelial cell apoptosis after lung injury[J]. Am J Respir Cell Mol Biol, 2012, 46(3):355-364.
|
| [38] |
Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease[J]. Nat Med, 2012, 18(7):1028-1040.
|
| [39] |
Richeldi L, Du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014, 370(22):2071-2082.
|
| [40] |
Günther S, Bordenave J, Hua-Huy T, et al. Macrophage migration inhibitory factor (MIF) inhibition in a murine model of Bleomycin-Induced pulmonary fibrosis[J]. Int J Mol Sci, 2018, 19(12): pii: E4105.
|
| [41] |
Cao ZW, Lis R, Ginsberg M, et al. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis[J]. Nat Med, 2016, 22(2):154-162.
|
| [42] |
Wynn TA. Integrating mechanisms of pulmonary fibrosis[J]. J Exp Med, 2011, 208(7):1339-1350.
|
| [43] |
Chambers RC. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?[J]. Br J Pharmacol, 2008, 153(Suppl 1):S367-S378.
|
| [44] |
Jagadapillai R, Rane MJ, Lin X, et al. Diabetic microvascular disease and pulmonary fibrosis: the contribution of platelets and systemic inflammation[J]. Int J Mol Sci, 2016, 17(11): pii: E1853.
|
| [45] |
Yang J, Wheeler SE, Velikoff M, et al. Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins[J]. Am J Pathol, 2013, 183(5):1559-1570.
|
| [46] |
Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis:from innocent targets to serial killers[J]. Proc Am Thorac Soc, 2006, 3(4):364-372.
|
| [47] |
Andersson-Sjöland A, De Alba CG, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis[J]. Int J Biochem Cell Biol, 2008, 40(10):2129-2140.
|
| [48] |
Heukels P, Van Hulst J, Van Nimwegen M, et al. Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis[J]. Respir Res, 2018, 19(1):90.
|
| [49] |
Margaritopoulos GA, Giannarakis I, Siafakas N. An update on idiopathic pulmonary fibrosis[J]. Panminerva Med, 2013, 55(2):109-120.
|